Developer docs
API playgroundTry for free, no card

Search company profiles

Hybrigenics Services

Full company profile

uuid000n2oo

Namestring
Hybrigenics Services
Legal namestring
Hybrigenics Services SAS
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Hybrigenics Services SAS is a privately held French bio-research services company headquartered at the Genopole Biopark in Evry-Courcouronnes, with regional offices in Boston (USA) and Kobe (Japan). Founded approximately 25 years ago, the company provides fee-for-service protein interaction discovery and synthetic nanobody (VHH) selection for academic research institutes, pharmaceutical and biotechnology companies, and agro-science laboratories worldwide. Its core technology platforms — ULTImate Y2H™ for exhaustive yeast two-hybrid screening of protein-protein, protein-DNA, protein-RNA, and small molecule interactions; YChemH for drug target deconvolution; Y2HChem for molecular glue and PROTAC interaction profiling; and Hybribody™ for animal-free synthetic nanobody selection — are supported by a content library spanning more than 130 cDNA libraries across 35 species, including 600+ human E3 ligases and a 14-million-clone cyclic peptide collection.

The company generates revenue primarily through professional services contracts: each customer engagement is a custom research project with quote-based pricing determined by service type, library complexity, and experimental scope. Sales are conducted directly via in-house scientific experts, with regional offices supporting North American and Japanese customers, and demand generation driven largely by scientific conference participation, customer publication showcasing, and a website resource center. The business has accumulated 3,000+ customers and 10,000+ screens over its history, with 700+ peer-reviewed customer publications as of 2025. Hybrigenics Services operates without disclosed institutional funding or a parent company, led by President Jean-Christophe Rain, and has expanded selectively through academic partnerships (e.g., Institut Curie, ANR-funded consortia) and one channel partnership for reagent commercialization (Nanotag GmbH for Ub-Selectors).

Short descriptiontext

Hybrigenics Services is a French bio-research services firm providing fee-for-service yeast two-hybrid protein interaction screening and synthetic nanobody (VHH) selection to academic, pharmaceutical, and agro-science customers worldwide via proprietary ULTImate Y2H, YChemH, and Hybribody platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersÉvry, France
HQ citystring
Évry
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
protein interaction screening, yeast two-hybrid services, nanobody selection, drug target discovery, molecular glue discovery
Industry4 codes
PRIMARYHLAAAIAA
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Protein Interaction Screening Services
TypeProfessional Services
Description

Fee-for-service scientific research services providing Y2H-based protein interaction screening, drug target identification, and molecular glue/PROTAC discovery using proprietary platforms and libraries.

hybrigenics-services.com
2Nanobody Selection and Validation Services
TypeProfessional Services
Description

Custom synthetic nanobody (VHH) selection, validation, and affinity maturation services using proprietary synthetic library and animal-free technologies.

hybrigenics-services.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Hybribody™
Description

Proprietary synthetic and humanized VHH library for customized nanobody selection, validation and affinity maturation projects.

hybrigenics-services.com
+2 more records
Core offering1 text field

Hybrigenics Services is a fee-for-service contract research organization performing protein-protein interaction discovery and synthetic nanobody (VHH) selection for academic, pharmaceutical, and agricultural researchers. Core platforms include ULTImate Y2H™ for exhaustive protein-protein/DNA/RNA/small molecule interaction screening, YChemH for drug target deconvolution, Y2HChem for molecular glue and PROTAC interaction profiling, and Hybribody™ for animal-free custom nanobody selection, validation, and affinity maturation, supported by a 130+ cDNA library collection spanning 35 species.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 700+ customer publications in peer-reviewed journals demonstrating scientific impact
+3 more records
Product overview1 text field

Hybrigenics Services is a research service provider offering a comprehensive portfolio of protein interaction discovery and nanobody selection platforms. The core offering centers on the ULTImate Y2H™ yeast two-hybrid technology platform for protein-protein interaction screening, complemented by the YChemH and Y2HChem platforms for drug target identification and molecular glue/PROTAC discovery. The Hybribody™ platform provides synthetic nanobody (VHH) selection, validation, and affinity maturation services using a proprietary library of over 3 billion variants. Supporting these platforms is an extensive collection of specialized cDNA libraries (130+ from 35+ species), including human E3 ligase library (600+ full-length ligases) and cyclic peptides library (14 million clones), enabling proteome-wide and targeted screening approaches for pharmaceutical, biotechnology, and academic research customers.

Product and service5 records
1ULTImate Y2H™ Protein Interaction Discovery
CategoryProtein interaction screening service
Description

Fee-for-service yeast two-hybrid (Y2H) screening that identifies protein-protein interactions as well as protein-DNA, protein-RNA, and small bioactive molecule interactions by screening customer-specified bait proteins against high-complexity cDNA libraries. Targets academic and pharma researchers needing unbiased, exhaustive interactome mapping without building in-house Y2H infrastructure.

2YChemH Drug-Target Deconvolution
CategoryDrug target identification service
Description

Chemical yeast three-hybrid screening service that identifies the protein targets of customer-supplied small bioactive molecules and elucidates their mode of action. Targeted at pharmaceutical and biotech researchers conducting polypharmacology studies, mechanism-of-action research, and drug target identification programs.

3Y2HChem Molecular Glues & PROTAC Interaction Discovery
CategoryMolecular glue and PROTAC discovery service
Description

Y2H-based screening service that identifies protein-protein interactions induced by small molecules, supporting molecular glue and PROTAC discovery and development programs. Targets pharma and biotech discovery teams working on targeted protein degradation and induced-proximity therapeutics.

4Hybribody™ Custom Nanobody (VHH) Selection, Validation and Affinity Maturation
CategoryNanobody selection service
Description

Custom synthetic and humanized VHH nanobody selection service using a proprietary library of over 3 billion variants, combining phage display with yeast two-hybrid for intrabody enrichment. Includes conformational intrabody selection, yeast-display–based affinity maturation, and minibody (Fc-fused VHH) production. Animal-free technology for use by academic, pharma, and diagnostic researchers.

5Ub-Selectors Ubiquitin Nanobodies
CategoryResearch reagent (licensed product)
Description

Ubiquitin-chain- and monoubiquitination-specific nanobodies developed using Hybrigenics' Hybribody technology and commercially distributed via Nanotag GmbH. Sold to life science researchers for ubiquitin-chain recognition, ubiquitylome analysis, and related research reagent applications.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1ANR MachActAssembly Project Consortium
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Collaborative ANR-funded research project with Alexis Gautreau laboratory (École Polytechnique/CNRS) and Raphael Guerois (I2BC) focusing on molecular machines assembly factors for cell migration in cancer research, using ULTImate Y2H screening.

hybrigenics-services.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-29
Description

Collaborative development of synthetic nanobody library with researchers Franck Perez and Sandrine Moutel at Institut Curie, Paris. This partnership contributed to the NaLi-H1 universal synthetic library of humanized nanobodies published in eLife 2016, which remains a cornerstone of Hybrigenics' Hybribody platform.

3European Network TauImmune (TAME)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

European doctoral training network advancing tau pathology research in Alzheimer's disease. Hybrigenics hosts secondments as part of this network, working on phospho-Tau-targeting nanobodies for diagnostic applications.

hybrigenics-services.com
4EU Marie Skłodowska-Curie Actions - ENDONANO ITN
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

European Industrial Doctorate training network bringing together academic and industrial partners to advance understanding of tau pathology in Alzheimer's disease and support development of new diagnostic strategies. Hybrigenics hosts secondments for doctoral researchers.

hybrigenics-services.com
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-01-01
Description

Nanotag GmbH commercializes Ubiquitin Selector Nanobodies developed by Hybrigenics. These reagents were selected using Hybrigenics' Hybribody technology to recognize ubiquitin chains and monoubiquitination, and are now available for purchase through Nanotag.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss Y2H and split-ubiquitin protein-interaction services company. Historically a direct competitor whose yeast activities were acquired by Hybrigenics in 2013; the residual IP, projects, and customer relationships make it the closest comparable operator in yeast-based PPI screening.

2MoBiTec
TypeDirect peer
Description

German supplier of yeast two-hybrid tools, screening libraries, and yeast-based services. Comparable as a yeastspecialist PPI service provider targeting academic and industrial customers in Europe.

TypeBroad incumbent
Description

France-headquartered global CRO arm of Eurofins offering protein sciences, screening and antibody services. Comparable as a broad-incumbent CRO that overlaps with Hybrigenics on biopharma and academic protein-interaction and custom reagent work.

TypeBroad incumbent
Description

Global biotech CRO with custom protein, antibody, and cell-line services. Overlaps with Hybrigenics on pharma and academic buyers needing custom protein-interaction and antibody-discovery services at industrial scale.

TypeBroad incumbent
Description

Large global CRO with broad discovery and safety-assessment services. Comparable as a diversified incumbent whose biopharma services compete with Hybrigenics for the same target-ID and custom screening budget.

TypeDirect peer
Description

Protein-interaction and proteomics services company. Comparable as a specialist CRO focused on yeast and mammalian protein-interaction work for pharma and academic customers.

TypeEmerging player
Description

Asia-based antibody-discovery CRO with extensive phage-display and nanobody capabilities. Comparable as an emerging player in the same nanobody/VHH service market that Hybrigenics' Hybribody platform addresses.

8Harbour BioMed
TypeEmerging player
Description

Biopharma and platform services company with a heavy nanobody/VHH franchise and transgenic鼠/全人源 antibody platforms. Overlaps with Hybrigenics on the upstream nanobody-discovery service layer for therapeutic and diagnostic programs.

TypeDirect peer
Description

US-based CRO offering custom antibody discovery, protein engineering, and protein-interaction services. Comparable as a direct service competitor for academic and pharma customers needing custom antibody and PPI work.

TypeOthers
Description

German reagent company commercializing ubiquitin-specific nanobodies selected via Hybrigenics' Hybribody technology. Comparable as an enabling downstream commercializer that converts Hybrigenics' service output into catalog reagents, illustrating the platform's product path.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hybrigenics Services

Contract Research Serviceshybrigenics-services.com

Hybrigenics Services is a French bio-research services firm providing fee-for-service yeast two-hybrid protein interaction screening and synthetic nanobody (VHH) selection to academic, pharmaceutical, and agro-science customers worldwide via proprietary ULTImate Y2H, YChemH, and Hybribody platforms.

What Hybrigenics Services does

Hybrigenics Services SAS is a privately held French bio-research services company headquartered at the Genopole Biopark in Evry-Courcouronnes, with regional offices in Boston (USA) and Kobe (Japan). Founded approximately 25 years ago, the company provides fee-for-service protein interaction discovery and synthetic nanobody (VHH) selection for academic research institutes, pharmaceutical and biotechnology companies, and agro-science laboratories worldwide. Its core technology platforms — ULTImate Y2H™ for exhaustive yeast two-hybrid screening of protein-protein, protein-DNA, protein-RNA, and small molecule interactions; YChemH for drug target deconvolution; Y2HChem for molecular glue and PROTAC interaction profiling; and Hybribody™ for animal-free synthetic nanobody selection — are supported by a content library spanning more than 130 cDNA libraries across 35 species, including 600+ human E3 ligases and a 14-million-clone cyclic peptide collection.

The company generates revenue primarily through professional services contracts: each customer engagement is a custom research project with quote-based pricing determined by service type, library complexity, and experimental scope. Sales are conducted directly via in-house scientific experts, with regional offices supporting North American and Japanese customers, and demand generation driven largely by scientific conference participation, customer publication showcasing, and a website resource center. The business has accumulated 3,000+ customers and 10,000+ screens over its history, with 700+ peer-reviewed customer publications as of 2025. Hybrigenics Services operates without disclosed institutional funding or a parent company, led by President Jean-Christophe Rain, and has expanded selectively through academic partnerships (e.g., Institut Curie, ANR-funded consortia) and one channel partnership for reagent commercialization (Nanotag GmbH for Ub-Selectors).

Hybrigenics Services firmographics

Firmographics
Name
Hybrigenics Services
Legal name
Hybrigenics Services SAS
Website
https://hybrigenics-services.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Hybrigenics Services is a French bio-research services firm providing fee-for-service yeast two-hybrid protein interaction screening and synthetic nanobody (VHH) selection to academic, pharmaceutical, and agro-science customers worldwide via proprietary ULTImate Y2H, YChemH, and Hybribody platforms.
Ownership category
akta.pro rank

Hybrigenics Services industry classification

Industry
Product category
Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAIAA
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Protein interaction screening
  • Yeast two-hybrid services
  • Nanobody selection
  • Drug target discovery
  • Molecular glue discovery

Where Hybrigenics Services is headquartered

Location

Headquarters

HQ city
Évry
HQ country
France
HQ region
Europe

Offices3 records

Markets served

Hybrigenics Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Protein Interaction Screening Services: Fee-for-service scientific research services providing Y2H-based protein interaction screening, drug target identification, and molecular glue/PROTAC discovery using proprietary platforms and libraries.
  2. Nanobody Selection and Validation Services: Custom synthetic nanobody (VHH) selection, validation, and affinity maturation services using proprietary synthetic library and animal-free technologies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Hybrigenics Services product offering

Product offering

Core offering

Hybrigenics Services is a fee-for-service contract research organization performing protein-protein interaction discovery and synthetic nanobody (VHH) selection for academic, pharmaceutical, and agricultural researchers. Core platforms include ULTImate Y2H™ for exhaustive protein-protein/DNA/RNA/small molecule interaction screening, YChemH for drug target deconvolution, Y2HChem for molecular glue and PROTAC interaction profiling, and Hybribody™ for animal-free custom nanobody selection, validation, and affinity maturation, supported by a 130+ cDNA library collection spanning 35 species.

Product overview

Hybrigenics Services is a research service provider offering a comprehensive portfolio of protein interaction discovery and nanobody selection platforms. The core offering centers on the ULTImate Y2H™ yeast two-hybrid technology platform for protein-protein interaction screening, complemented by the YChemH and Y2HChem platforms for drug target identification and molecular glue/PROTAC discovery. The Hybribody™ platform provides synthetic nanobody (VHH) selection, validation, and affinity maturation services using a proprietary library of over 3 billion variants. Supporting these platforms is an extensive collection of specialized cDNA libraries (130+ from 35+ species), including human E3 ligase library (600+ full-length ligases) and cyclic peptides library (14 million clones), enabling proteome-wide and targeted screening approaches for pharmaceutical, biotechnology, and academic research customers.

Differentiator

Problem solved

Functional benefit

Brands

  • Hybribody™: Proprietary synthetic and humanized VHH library for customized nanobody selection, validation and affinity maturation projects.
  • ULTImate Y2H™
  • YChemH™

Products and services

  • ULTImate Y2H™ Protein Interaction Discovery Fee-for-service yeast two-hybrid (Y2H) screening that identifies protein-protein interactions as well as protein-DNA, protein-RNA, and small bioactive molecule interactions by screening customer-specified bait proteins against high-complexity cDNA libraries. Targets academic and pharma researchers needing unbiased, exhaustive interactome mapping without building in-house Y2H infrastructure.
  • YChemH Drug-Target Deconvolution Chemical yeast three-hybrid screening service that identifies the protein targets of customer-supplied small bioactive molecules and elucidates their mode of action. Targeted at pharmaceutical and biotech researchers conducting polypharmacology studies, mechanism-of-action research, and drug target identification programs.
  • Y2HChem Molecular Glues & PROTAC Interaction Discovery Y2H-based screening service that identifies protein-protein interactions induced by small molecules, supporting molecular glue and PROTAC discovery and development programs. Targets pharma and biotech discovery teams working on targeted protein degradation and induced-proximity therapeutics.
  • Hybribody™ Custom Nanobody (VHH) Selection, Validation and Affinity Maturation Custom synthetic and humanized VHH nanobody selection service using a proprietary library of over 3 billion variants, combining phage display with yeast two-hybrid for intrabody enrichment. Includes conformational intrabody selection, yeast-display–based affinity maturation, and minibody (Fc-fused VHH) production. Animal-free technology for use by academic, pharma, and diagnostic researchers.
  • Ub-Selectors Ubiquitin Nanobodies Ubiquitin-chain- and monoubiquitination-specific nanobodies developed using Hybrigenics' Hybribody technology and commercially distributed via Nanotag GmbH. Sold to life science researchers for ubiquitin-chain recognition, ubiquitylome analysis, and related research reagent applications.

Quantifiable outcome

  • 700+ customer publications in peer-reviewed journals demonstrating scientific impact
  • +3 more outcomes

Companies that use Hybrigenics Services

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Hybrigenics Services technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Hybrigenics Services partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • ANR MachActAssembly Project ConsortiumminorStrategic or Co-development Partner · 1 March 2026Collaborative ANR-funded research project with Alexis Gautreau laboratory (École Polytechnique/CNRS) and Raphael Guerois (I2BC) focusing on molecular machines assembly factors for cell migration in cancer research, using ULTImate Y2H screening.
  • Institut CuriecoreStrategic or Co-development Partner · 29 September 2025Collaborative development of synthetic nanobody library with researchers Franck Perez and Sandrine Moutel at Institut Curie, Paris. This partnership contributed to the NaLi-H1 universal synthetic library of humanized nanobodies published in eLife 2016, which remains a cornerstone of Hybrigenics' Hybribody platform.
  • European Network TauImmune (TAME)minorStrategic or Co-development Partner · 1 September 2025European doctoral training network advancing tau pathology research in Alzheimer's disease. Hybrigenics hosts secondments as part of this network, working on phospho-Tau-targeting nanobodies for diagnostic applications.
  • EU Marie Skłodowska-Curie Actions - ENDONANO ITNminorStrategic or Co-development Partner · 1 January 2024European Industrial Doctorate training network bringing together academic and industrial partners to advance understanding of tau pathology in Alzheimer's disease and support development of new diagnostic strategies. Hybrigenics hosts secondments for doctoral researchers.
  • Nanotag GmbHminorChannel Partner/ Reseller/ Distributor · 1 January 2022Nanotag GmbH commercializes Ubiquitin Selector Nanobodies developed by Hybrigenics. These reagents were selected using Hybrigenics' Hybribody technology to recognize ubiquitin chains and monoubiquitination, and are now available for purchase through Nanotag.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Hybrigenics Services competitors and assessment

Company assessment

Direct peers

  • Dualsystems Biotech: Swiss Y2H and split-ubiquitin protein-interaction services company. Historically a direct competitor whose yeast activities were acquired by Hybrigenics in 2013; the residual IP, projects, and customer relationships make it the closest comparable operator in yeast-based PPI screening.
  • MoBiTec: German supplier of yeast two-hybrid tools, screening libraries, and yeast-based services. Comparable as a yeastspecialist PPI service provider targeting academic and industrial customers in Europe.
  • ProtaGene: Protein-interaction and proteomics services company. Comparable as a specialist CRO focused on yeast and mammalian protein-interaction work for pharma and academic customers.
  • Creative Biolabs: US-based CRO offering custom antibody discovery, protein engineering, and protein-interaction services. Comparable as a direct service competitor for academic and pharma customers needing custom antibody and PPI work.

Broad incumbents

  • Eurofins Discovery: France-headquartered global CRO arm of Eurofins offering protein sciences, screening and antibody services. Comparable as a broad-incumbent CRO that overlaps with Hybrigenics on biopharma and academic protein-interaction and custom reagent work.
  • GenScript: Global biotech CRO with custom protein, antibody, and cell-line services. Overlaps with Hybrigenics on pharma and academic buyers needing custom protein-interaction and antibody-discovery services at industrial scale.
  • Charles River Laboratories: Large global CRO with broad discovery and safety-assessment services. Comparable as a diversified incumbent whose biopharma services compete with Hybrigenics for the same target-ID and custom screening budget.

Emerging players

  • Biocytogen: Asia-based antibody-discovery CRO with extensive phage-display and nanobody capabilities. Comparable as an emerging player in the same nanobody/VHH service market that Hybrigenics' Hybribody platform addresses.
  • Harbour BioMed: Biopharma and platform services company with a heavy nanobody/VHH franchise and transgenic鼠/全人源 antibody platforms. Overlaps with Hybrigenics on the upstream nanobody-discovery service layer for therapeutic and diagnostic programs.

Others

  • Nanotag Biotechnologies: German reagent company commercializing ubiquitin-specific nanobodies selected via Hybrigenics' Hybribody technology. Comparable as an enabling downstream commercializer that converts Hybrigenics' service output into catalog reagents, illustrating the platform's product path.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hybrigenics Services social profiles

Digital presence

Hybrigenics Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hybrigenics Services leadership team

Management profile

Number of profiles

Profiles1 record

Hybrigenics Services subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hybrigenics Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hybrigenics Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hybrigenics Services

What does Hybrigenics Services do?

Hybrigenics Services is a fee-for-service contract research organization performing protein-protein interaction discovery and synthetic nanobody (VHH) selection for academic, pharmaceutical, and agricultural researchers. Core platforms include ULTImate Y2H™ for exhaustive protein-protein/DNA/RNA/small molecule interaction screening, YChemH for drug target deconvolution, Y2HChem for molecular glue and PROTAC interaction profiling, and Hybribody™ for animal-free custom nanobody selection, validation, and affinity maturation, supported by a 130+ cDNA library collection spanning 35 species.

Is Hybrigenics Services a public or private company?

Hybrigenics Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Hybrigenics Services founded?

Hybrigenics Services was founded in 2000. It employs 11 to 50 people.

Where is Hybrigenics Services based?

Hybrigenics Services is headquartered in Évry, France, in the Europe region.

How does Hybrigenics Services make money?

Two revenue lines are on record. Protein Interaction Screening Services are the primary driver. The others are nanobody Selection and Validation Services.

Who are Hybrigenics Services's main competitors?

Direct peers on record are Dualsystems Biotech, MoBiTec, ProtaGene and Creative Biolabs. Broad incumbents are Eurofins Discovery, GenScript and Charles River Laboratories. Emerging players are Biocytogen and Harbour BioMed. Nanotag Biotechnologies is listed as an others.

Does Hybrigenics Services have an API?

No public API is recorded for Hybrigenics Services.

What industry is Hybrigenics Services in?

Hybrigenics Services's product category is Contract Research Services. Its primary akta.pro industry code is HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening), with a secondary code of HLAAAIAI, Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales